Results 321 to 330 of about 87,634 (337)
Some of the next articles are maybe not open access.
HL-A Antigens and Acute Lymphocytic Leukemia
American Journal of Clinical Pathology, 1974Twenty-four children with acute lymphocytic leukemia were compared with unmatched, unrelated normal controls for 20 HL-A specificities. No association between HL-A specificities and susceptibility to acute leukemia could be established. However, additional cytotoxic reactions were observed in the lymphocytes of three of six patients when malignant ...
John Bernard Henry+2 more
openaire +3 more sources
Lymphocyte glutathione levels in acute leukemia
Clinica Chimica Acta, 1999The current interest in the clinical significance of the glutathione estimation in leukemia is due to its widespread effect on the cell constituent and cell function of the hematopoietic system. It helps and protects the cells against free radicals and reactive oxygen products.
Amit Rawal+3 more
openaire +3 more sources
PROGENY OF SURVIVORS OF ACUTE LYMPHOCYTIC LEUKEMIA
Acta Paediatrica, 1979Abstract. Eight successful pregnancies and one spontaneous abortion have been observed in 5 women belonging to a group of 212 Nordic children who had their antileukemic therapy discontinued before January 1, 1978. Furthermore a young leukemic man was the father of a healthy child after 4 years of intensive cytostatic therapy.
P. J. Moe+5 more
openaire +3 more sources
Treatment of Acute Lymphocytic Leukemia in Uganda
Acta Haematologica, 1975The hematologic remission rate of 17 black Ugandan children with acute lymphocytic leukemia treated with prednisone and vincristine was 41%. There was no correlation of the remission rate with any clinical or laboratory finding at the time of diagnosis.
openaire +3 more sources
Cytomegaloviremia in children with acute lymphocytic leukemia
The Journal of Pediatrics, 1975Leukocyte and urine cultures were done at monthly intervals in 36 children with acute lymphocytic leukemia known to be excreting cytomegalovirus in their or saliva in order to determine the relationship of viremia to clinical cytomegalic inclusion disease. Eleven of 36 (30.5%) patients had viremia.
Walter T. Hughes, Frederick Cox
openaire +3 more sources
Seminoma in an Adult with Acute Lymphocytic Leukemia
Journal of Urology, 1986We present a unique case of a seminoma in an adult with acute lymphocytic leukemia in clinical remission. As survival improves with modern multimodal chemotherapy testicular relapse of acute lymphocytic leukemia is becoming more common. A histopathological diagnosis is needed to initiate appropriate local and systemic therapy.
Mark C. Musmanno, J.M. White
openaire +3 more sources
Acute non-lymphocytic leukemia with t(16;21)
Cancer Genetics and Cytogenetics, 1993A patient with ANLL FAB subtype M1 was found to possess a t(16;21)(p11;q22) and trisomy 10. The 16;21 translocation has been reported in 12 other cases of ANLL, of various subtypes, and its relationship to the disease profile is discussed.
J.A. Copplestone+4 more
openaire +3 more sources
Total Therapy of Acute Lymphocytic Leukemia
JAMA: The Journal of the American Medical Association, 1972In 1962, the total therapy approach to acute lymphocytic leukemia was developed at St. Jude Children's Research Hospital. Briefly, it consists of rapid and efficient induction of complete remission with prednisone and vincristine in order to minimize early attrition, cranial or craniospinal irradiation during the first month of complete remission to ...
openaire +3 more sources
CYTOGENETICS IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA
Hematology/Oncology Clinics of North America, 2000The outcome of adult ALL patients has improved over the years, with an increase in median DFS from 0.9 years before 1988 to 1.7 years alter 1988. There is still ample room for improvement. Cytogenetic analysis at diagnosis can assist in developing risk-adapted therapeutic strategies and in devising new treatment modalities by an understanding of the ...
openaire +3 more sources
The treatment of acute non-lymphocytic leukemia
Blood Reviews, 1987The treatment of acute nonlymphocytic leukemia involves a two stage approach. During the first stage, remission induction, cytotoxic drugs are administered to return hematopoiesis to normal. During the second stage, therapy is administered in an attempt to prolong the duration of remission. The clinical approaches and the problems incurred during these
openaire +3 more sources